Similarly, overexpression of the E3 ligase Parkin, described below for its role in PD, has been shown to reduce APP expression, Amyloid-Beta burden, and inflammation while also restoring the formation of long-term hippocampal synaptic potentiation in an AD mouse model (Hong et al., 2014). Here, PRKN is linked to Parkinson disease.